Literature DB >> 8103319

Paraganglioma of the urinary bladder: an immunohistochemical study and report of an unusual association with intestinal carcinoid.

K Y Lam1, A C Chan.   

Abstract

Two cases of paraganglioma of the urinary bladder are reported. Their immunohistochemical profiles and the clinical features are compared with other cases in the literature. The three pan-endocrine markers (neuron-specific enolase, synaptophysin and chromogrannin) were positive in both cases. Positivity to other neuropeptides (including the present two cases and those in literature) includes adrenocorticotropic hormone (three out of five cases), calcitonin (two out of nine cases), gastrin (two out of six cases), glial fibrillary acidic protein (one out of five cases), glucagon (two out of six cases), serotonin (five out of nine cases), and somatostatin (four out of eight cases). A previously unmentioned association between paraganglioma of the urinary bladder and carcinoid in the gastrointestinal tract is noted in one of the present cases. This peculiar association highlights the importance of multiplicity of tumours of the neuroendocrine system other than the classical multiple endocrine neoplasia syndromes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103319     DOI: 10.1111/j.1445-2197.1993.tb00507.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  3 in total

Review 1.  Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature.

Authors:  Kais Kasem; Alfred K-Y Lam
Journal:  Endocr Pathol       Date:  2014-12       Impact factor: 3.943

2.  The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas.

Authors:  K Y Lam; C Y Lo; N M Wat; J M Luk; K S Lam
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

Review 3.  Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.

Authors:  Alfred King-Yin Lam
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.